 |
|
|
| |
Treatment of Hepatitis C Virus (HCV) Leads to Economic Gains Related to Reduction in Cases of Hepatocellular Carcinoma (HCC) and Decompensated Cirrhosis (DCC) in Japan
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
Zobair M. Younossi1,2, Atsushi Tanaka3, Yuichiro Eguchi4, Linda Henry5, Rachel Beckerman6, Masashi Mizokami7
1Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA
2Department of Medicine, Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA
3Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan
4Liver Center, Saga University Hospital, Saga University, Saga, Japan.
5Center for Outcomes Research in Liver Diseases, Washington, DC
6Maple Health Group LLC, New York, NY
7National Center for Global Health and Medicine, Tokyo, Japan
|
| |
|
|
|
|
|
